replicor.com
Replicor… 🔗
#5,096,931
Global Rankeez rank — last updated 01 Sep 2026
Better than 94.9% of the 99,976,913 domains we track
Best rank recorded
#5,011,025
2026-07
Worst rank recorded
#6,323,626
2026-08
Tracked since
2026-07
4 monthly snapshots
Source breakdown
Rankeez combines several independent public rankings. Here's how replicor.com scores in each:
| Source | Rank |
|---|---|
| DomCop / OpenPageRank | #3,247,185 |
| CommonCrawl (hyperlink graph) | #16,002,438 |
See how these sources are combined and cross-validated →
Ranking history
replicor.com's rank across 4 monthly snapshots. ▼ dropped by 85,906 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #5,011,025 |
| 2026-08 | #6,323,626 |
| 2026-09 | #5,096,931 |
| 2026-10 | #5,096,931 |
JSON API
{
"replicor.com": 5096931,
"history": {
"2026-07": 5011025,
"2026-08": 6323626,
"2026-09": 5096931,
"2026-10": 5096931
}
}
GET https://rankeez.com/api/replicor.com.json · see API docs →
More about replicor.com
replicor.com — page content & similar sites →
Science Overview Replicor is a clinical-stage biopharmaceutical company developing NUCLEIC ACID POLYMERS (NAPs). These compounds are oligonucleotides whose antiviral activity is strictly dependent on the sequence independent activity of phosphorothioate
replicor.com — full site profile →
WHOIS, tech stack and extended traffic history for replicor.com.